SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Rapid antidepressant effects associated with ketamine have shifted the landscape for the

PDF) Cannabinoids and Vanilloids in Schizophrenia

PDF) Cannabinoids and Vanilloids in Schizophrenia

NMDA Antagonists and Their Role in the Management of Bipolar

Depolarizing GABAA current in the prefrontal cortex is linked with

Alteration of NMDA receptor trafficking as a cellular hallmark of

PDF) Does mismatch negativity have utility for NMDA receptor drug

PDF) Neuroprogression in schizophrenia: Pathways underpinning

Molecular mechanisms underlying the antidepressant actions of

Frontiers Targeting mGlu Receptors for Optimization of

NMDA receptor-targeted enrichment of CaMKIIα improves fear memory